What is the most recent earnings date for TPST stock?
TEMPEST THERAPEUTICS INC (TPST) last reported earnings on 3/25/2026.
NASDAQ:TPST • US87978U2078
Past quarterly earnings results for TEMPEST THERAPEUTICS INC (TPST), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.79 | -3.34 | 76.31% | 85.18% | - | - | ||
| Q2 2025 | -2.07 | -2.66 | 22.10% | 62.09% | - | - | ||
| Q1 2025 | -3.16 | -3.36 | 5.93% | 32.48% | - | - | ||
| Q4 2024 | -4.03 | -3.34 | -20.60% | 18.42% | - | - | ||
| Q3 2024 | -5.33 | -4.80 | -11.04% | 14.58% | - | - | ||
| Q2 2024 | -5.46 | -5.34 | -2.17% | 22.22% | - | - | ||
| Q1 2024 | -4.68 | -4.96 | 5.68% | 34.55% | - | - | ||
| Q4 2023 | -4.94 | -5.12 | 3.43% | 39.68% | - | - | ||
| Q3 2023 | -6.24 | -7.59 | 17.84% | 27.27% | - | - | ||
| Q2 2023 | -7.02 | -6.86 | -2.30% | 31.65% | - | - | ||
| Q1 2023 | -7.15 | -8.52 | 16.04% | 53.39% | - | - | ||
| Q4 2022 | -8.19 | -10.06 | 18.62% | 43.78% | - | - | ||
| Q3 2022 | -8.58 | -10.64 | 19.37% | 45.45% | - | - | ||
| Q2 2022 | -10.27 | -12.24 | 16.12% | 89.65% | - | - | ||
| Q1 2022 | -15.34 | -14.81 | -3.60% | 82.12% | - | - | ||
| Q4 2021 | -14.57 | -16.35 | 10.93% | 80.85% | - | - | ||
| Q3 2021 | -15.73 | -13.88 | -13.34% | 76.27% | - | - | ||
| Q2 2021 | -99.19 | -11.60 | -754.90% | 9.17% | - | - | ||
| Q1 2021 | -85.80 | -69.62 | -23.25% | 32.31% | - | - | ||
| Q4 2020 | -76.05 | -68.29 | -11.37% | - | - | - | ||
| Q3 2020 | -66.30 | -91.49 | 27.54% | - | - | - | ||
| Q2 2020 | -109.20 | -108.73 | -0.43% | - | - | - | ||
| Q1 2020 | -126.75 | -132.60 | 4.41% | - | - | - |
Notes
TEMPEST THERAPEUTICS INC (TPST) last reported earnings on 3/25/2026.
TEMPEST THERAPEUTICS INC (TPST) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, TEMPEST THERAPEUTICS INC (TPST) has beaten EPS estimates in 3 out of 4 releases.